tiprankstipranks
Trending News
More News >
BioLargo Inc (BLGO)
OTHER OTC:BLGO
US Market

BioLargo (BLGO) Financial Statements

Compare
63 Followers

BioLargo Financial Overview

BioLargo's market cap is currently $64.17M. The company's EPS TTM is $; its P/E ratio is ―; BioLargo is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 17.78M$ 12.23M$ 5.88M$ 2.53M$ 2.43M
Gross Profit$ 7.85M$ 6.15M$ 2.86M$ 1.10M$ 1.23M
Operating Income$ -4.33M$ -4.19M$ -5.12M$ -6.38M$ -7.45M
EBITDA$ -4.06M$ -4.19M$ -5.10M$ -6.70M$ -7.83M
Net Income$ -2.40M$ -3.50M$ -4.50M$ -7.38M$ -10.47M
Balance Sheet
Cash & Short-Term Investments$ 3.55M$ 3.54M$ 1.85M$ 962.00K$ 716.00K
Total Assets$ 10.51M$ 8.21M$ 4.86M$ 3.02M$ 4.94M
Total Debt$ 2.55M$ 1.70M$ 1.47M$ 1.13M$ 2.67M
Net Debt$ -994.00K$ -1.84M$ -383.00K$ 171.00K$ 1.96M
Total Liabilities$ 4.46M$ 4.00M$ 2.85M$ 2.09M$ 5.18M
Stockholders' Equity$ 8.85M$ 6.84M$ 4.88M$ 4.65M$ 3.86M
Cash Flow
Free Cash Flow$ -4.44M$ -2.84M$ -3.03M$ -3.97M$ -4.18M
Operating Cash Flow$ -3.21M$ -2.37M$ -2.76M$ -3.94M$ -4.15M
Investing Cash Flow$ -1.32M$ -478.00K$ -271.00K$ -34.00K$ -123.00K
Financing Cash Flow$ 4.44M$ 4.66M$ 3.96M$ 4.23M$ 4.34M
Currency in USD

BioLargo Earnings and Revenue History

BioLargo Debt to Assets

BioLargo Cash Flow

BioLargo Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis